Under pressure, Mylan plans to boost access to its EpiPen Auto-Injector by expanding existing programs for patients who are facing higher costs. » Read More
CVS Health's new "excluded" list includes medications used in treatment of patients with cancer, diabetes and hepatitis C.
Biogen shares soared on reports the company has drawn takeover interest from rival companies, the Wall Street Journal said.
CDC Director Tom Frieden says pregnant women all over the South should protect themselves against mosquito bites because of the risk of Zika.
Pfizer's results were driven by lower taxes and demand for new medicines, but it stuck to its previous sales and profit forecasts for the full year.
Theranos CEO Elizabeth Holmes pledged on Monday to increase transparency regarding its testing methods.
Most claims of opioid dependence involved adults between the ages of 19 and 35.
Theranos CEO Elizabeth Holmes will make her case to the biggest summit of experts in her field, but can she convince them her technology works?
Biogen and Ionis Pharmaceuticals shares soared after an analysis showed a drug for a deadly muscle disorder in infants met its main goal.
GlaxoSmithKline and Alphabet's life sciences unit are creating a new company focused on fighting diseases.
Seres Therapeutics shares plummeted more than 76 percent after its drug for preventing a bacterial infection of the large intestine failed.
Florida Gov. Rick Scott said that his state has become the first state in the nation to have the Zika virus transmitted locally via mosquitoes.
AbbVie's quarterly net revenue jumped 17.8 percent, driven by demand for its top-selling treatment, Humira.
The company's new tool will give small companies a quick, easy way to evaluate group plan costs.
New overall quality star ratings can help consumers chose among hospitals for themselves and loved ones.
Alere is still is trying to close its multibillion-dollar purchase by Abbott Labs.
"Consumers got better coverage" even as the average premiums paid for individual health plans dropped in 2014, an analysis found.
Get the best of CNBC in your inbox